Floatz logo

Marcaine

Raynaud Disease

Jose Soberon, MDSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Raynaud Disease cohort.

Asset / SponsorPhaseRating
Oxygen
Jay C. Buckey Jr.
Phase 4BB
Iloprost
National Center for Research Resources (NCRR)
Phase 3BB
Selexipag
Actelion
Phase 2B
pf-00489791
Pfizer
Phase 2B
Nitric Oxide
RoseLab Skin Optics Laboratory
UnknownNR

Same molecule, other indications

Marcaine is also rated in:

migraine disorderActive
BBB
Indicative · Phase 4
74 / 100
View asset →
neuralgiaActive
BBB
Indicative · Phase 4
74 / 100
View asset →
headache disorderActive
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →